Results 171 to 180 of about 22,335 (252)

L-carnitine in metabolic dysfunction-associated steatotic liver disease: mechanisms and therapeutic potential. [PDF]

Front Nutr
Chen C, Zou J, Li L, Liu S, Liu Z, Yao L, Peng P, Liang J, Chen Z, Huang H, Huang J.   +10 more
europepmc   +1 more source

Clinical Outcomes of Gradual Corticosteroid Tapering for Immune Checkpoint Inhibitor‐Induced Liver Injury

Hepatology Research, EarlyView.
Patients with severe ICI‐induced liver injury are commonly treated with corticosteroids, but the optimal tapering strategy remains uncertain. In this study, a gradual corticosteroid tapering strategy based partly on Japanese clinical practice for autoimmune hepatitis was associated with a low rate of relapse and enabled many patients to safely resume ...
Naoto Soma, Yoshihito Uchida, Kayoko Sugawara, Masamitsu Nakao, Nobuaki Nakayama, Yukinori Imai, Suguru Mizuno, Satoshi Mochida   +7 more
wiley   +1 more source

Association Between Periodontitis and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Cross-Sectional Study. [PDF]

Clin Exp Dent Res
Saito M, Shimazaki Y, Yoshii S, Kojima T.   +3 more
europepmc   +1 more source

Steatotic liver disease. literature review

Šiame baigiamajame darbe steatozinė kepenų liga nagrinėjama taip, kaip ji suprantama šiandien – ne tik kaip dažnas kepenų sutrikimas, bet ir kaip būklė, kurios samprata keitėsi kartu su terminijos pokyčiais, platesniu metaboliniu kontekstu ir niuansuotesniu požiūriu į prognozę.
openaire   +1 more source

UltRaSoUnd‐guided evaLuAtion of metabolic health in a cohort of midlife women with HIV: The URSULA study

HIV Medicine, EarlyView.
Abstract Objectives We aimed to determine the prevalence of metabolic disorders, liver steatosis and metabolic dysfunction‐associated steatotic liver disease (MASLD) in a cohort of middle‐aged women with HIV (WoWH) and to explore associations between liver steatosis, visceral fat depots and carotid atherosclerosis.
Mariacristina Poliseno, Davide Capruzzi, Antonio Cianciaruso, Nicola Colavito, Felicia Dalitto, Vincenzo Giliberti, Vittoria Lobalsamo, Giuliana Metrangolo, Marica Noviello, Alessandra Vigna, Maurizio Zarcone, Francesco Di Gennaro, Vincenzo Ostilio Palmieri, Annalisa Saracino   +13 more
wiley   +1 more source

Integrative genetic and liver transcriptomic analyses identify TRIB1AL as a target for steatotic liver disease.

J Clin Endocrinol Metab
Gobeil É, Bourgault J, Gagnon E, Samson N, Ruel LJ, Côté V, Mitchell PL, Gotti C, Roux-Dalvai F, Droit A, Bossé Y, Mathieu P, Lajeunesse-Trempe F, Vohl MC, Caron A, Tchernof A, Thériault S, Laplante M, Arsenault BJ.   +18 more
europepmc   +1 more source

Effect of cholecystectomy on liver fat and fibrosis in metabolic dysfunction-associated steatotic liver disease patients. [PDF]

World J Gastrointest Pharmacol Ther
Amalou K, Belal N, Tibouk A, Ghedada Y, Rekab R, Fadel S, Debzi N, Bousloub A.   +7 more
europepmc   +1 more source

Semaglutide improves MASLD and MASH in people with HIV: The SLIM LIVER study

HIV Medicine, EarlyView.
Abstract Objectives We have shown that semaglutide, a glucagon‐like peptide‐1 receptor agonist (GLP‐1RA), is a highly effective therapy for metabolic dysfunction‐associated steatotic liver disease (MASLD) in people with HIV (PWH). The OWLiver® metabolomics algorithms allow non‐invasive MASLD severity staging without liver biopsy, but the use of ...
Jordan E. Lake, Douglas W. Kitch, Amy Kantor, Rebeca Mayo, Pablo Belaunzaran‐Zamudio, Carl J. Fichtenbaum, Todd T. Brown, Kathleen E. Corey, Fred Sattler, Kristine M. Erlandson   +9 more
wiley   +1 more source

Diagnostic innovation and models of care to improve fibrosis detection and risk stratification in steatotic liver disease. [PDF]

Lancet Reg Health Eur
Pugliese N, White TM, Brennan PN, Pannain S, Hagström H, Michel M, Rice-Duek L, Targher G, Caussy C, Dillon JF, Tacke F, Kopka CJ, Sebastiani G, Boursier J, Tsochatzis EA, Brouwer WP, Guaraldi G, Vettor R, Thiele M, Roden M, Stefan N, Jarvis H, Gines P, Schattenberg JM, Pose E, Buttigieg S, Byrne CD, Lazarus JV.   +27 more
europepmc   +1 more source